Skip to main content
generic tablet hero

Lupin debuts generic Myrbetriq

Myrbetriq is indicated for the treatment of overactive bladder.
Levy

Lupin is introducing mirabegron extended-release tablets, 25 mg, which is a generic of Astellas Pharma’s Myrbetriq.

[Read more: Lupin receives FDA OK for generic Banzel]

Myrbetriq is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and urinary frequency.

Mirabegron extended-release tablets, 25 mg had a market value of $1.1 billion, per IQVIA  February 2024 data.

X
This ad will auto-close in 10 seconds